D
Draupnir Bio
0 followers
Draupnir Bio intends to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company is developing a platform for exploring the glycome to develop novel therapeutics, based on array technology, protein chemistry, a... Read more
Org chart
Andrew Hotchkiss
Chief Executive Officer
Andrew Hotchkiss
Collapse
Camilla Gustafsen
VP Biology
Casper Tind Hansen
Chief Business Officer
Joachim Pold Vilstrup
Co-founder Of Draupnir Bio
Simon Feldbæk Nielsen
Chief Technology Officer (Head of R&D)
Simon Glerup
CSO
Teams
This company has no teams yet